Banking

Stocks With Rising Composite Ratings: Bio-Techne

Bio-Techne (TECH) saw an improvement in its IBD SmartSelect Composite Rating Tuesday, from 93 to 97.




X



The upgrade means the stock currently tops 97% of all other stocks in terms of key performance metrics and technical strength.

Bio-Techne is now out of buy range after clearing the 444.93 buy point in a flat base.


Looking For The Best Stocks To Buy And Watch? Start Here


The stock earns an 87 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth tops 87% of all stocks.

Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.

In Q4, the company reported 87% EPS growth. Sales growth increased 47%, up from 25% in the prior quarter. The company has now posted increasing growth in each of the last four quarters.

Bio-Techne holds the No. 6 rank among its peers in the Medical-Research Equipment/Services industry group. Agilent Technologies (A), Avantor (AVTR) and Charles River Labs International (CRL) are among the top 5 highly-rated stocks within the group.

YOU MIGHT ALSO LIKE:

Which Companies Are Now Outperforming 95% Of All Stocks?

See Which Stocks Just Came On — And Off — IBD’s Top Stock Lists

See How To Reduce Risk, Increase Profits With Swing Trading

Most Related Links :
reporterwings Governmental News Finance News

Source link

Back to top button